The wall-less procaryote Mycoplasma fermentans is currently being examined as an agent potentially associated with human disease, including infectious processes affecting immunocompromised individuals. To delineate and understand the interactions of M. fermentans with its host, specific membrane surface components were characterized as markers for detecting the organism and for assessing heterogeneity in antigenic surface architecture within this mycoplasma species. Detergent phase fractionation of metabolically labeled organisms of type strain PG18 identified a family of prominent integral membrane proteins; several of these labeled with 35S-cysteine and 3H-palmitate, which are characteristics of procaryotic lipoproteins. Specific monoclonal and polyclonal antibodies raised to strain PG18 components further distinguished seven of these membrane proteins, which were localized on the organism's surface by monitoring their selective susceptibility during trypsin treatment of intact cells. With these antibodies, Western immunoblot profiles of surface membrane antigens expressed on strain PG18 were compared with those expressed on the recently identified Incognitus strain ofM.fermentans, as well as with several other human and animal mycoplasma species. While the antibodies were specific for M.fermentans, marked differences were observed between the strains in the size of one surface lipoprotein and in the apparent levels of several antigens expressed in the cultured populations analyzed. Some monoclonal antibodies to strain PG18 and a previously described monoclonal antibody to strain Incognitus showed apparent selectivity for the strain used for immunization. Monoclonal antibodies developed here recognize stable epitopes defining a family of surface lipoproteins and provide critical tools to determine the basis of surface variation in this mycoplasma species and to assess the location and antigenic phenotypes of organisms in the human host.
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Over 90 species are now assigned to the genus Mycoplasma (11) . Most have been identified as infectious agents of humans or other animals, and many are established pathogens (17, 21) . The survival strategies used by these small wall-less procaryotes are largely unknown, as are the pathways by which some species express their pathogenic potential. Characterization of mycoplasma surface architecture is becoming increasingly appreciated as a requisite for understanding the interactions of these organisms with their hosts. For example, complex genetic mechanisms driving structural diversification at the membrane surface have been revealed in some mycoplasma pathogens (9, 12, 13, 30) , and descriptive features of antigenic surface variability have now emerged for several species (reviewed in reference 27). A general issue in understanding mycoplasma-host interactions is the need to define surface constituents, both as indicators of potential diversity in these organisms and as gene products functionally contributing to their adaptive capabilities (24) .
Mycoplasma fermentans is an infectious agent of the human host. Type strain PG18 was derived several decades ago from an isolate of the urogenital tract (4, 10, 14) . However, interest in this mycoplasma has recently increased because of reports indicating its presence at disease lesions in several organs affected during pathologic conditions in immunocompromised individuals with AIDS and in patients without apparent immune dysfunction (7) . Similar lesions are reported to occur in nonhuman primates inoculated with * Corresponding author.
the recently described Incognitus strain of M. fermentans (7) . Further assessment of the role of M. fermentans in human disease would be facilitated by the development of useful markers to determine its presence, location, and phenotypic diversity in the host. The need to assess phenotypic variability stems from growing evidence of diversification in many mycoplasma species and from the confounding effect this phenomenon imposes on attempts to link specific phenotypes with pathogenic properties of particular strains or isolates (27) . Serologically based approaches to monitor infection may also be severely limited without a clear understanding of the specific antigenic structure and stability of the organism. Finally, the characteristic low success rate in isolating these organisms requires that methods be developed to identify this agent and its phenotypic alternatives as it resides in the host.
With these aims in mind, we have investigated the surface membrane proteins of M. fennentans in an attempt to define markers that identify the species as well as the specific structural elements possibly contributing to intraspecies heterogeneity in surface architecture. Using strategies developed previously to detect mycoplasma surface lipoprotein antigens, we demonstrate a family of such products in M. fermentans, some of which appear to show differences in their surface profiles within the species.
Research Resources Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md., and was propagated in modified Hayflick medium (26) supplemented with 10% (vol/vol) heat-inactivated horse serum (JRH Biosciences, Lenexa, Kans.). M. fennentans Incognitus was isolated and propagated in SP4 medium as described previously (8) . Unless specified otherwise, organisms were harvested from logarithmic-phase cultures by centrifugation, washed in phosphate-buffered saline (PBS; 2.7 mM KCl, 1.5 mM KH2PO4, 137 mM NaCl, 8 mM Na2HPO4; pH 7.2), and stored at -70°C prior to use. Other human mycoplasmas were obtained from J. Tully, Frederick Cancer Research and Development Center, Frederick, Md., as frozen broth cultures. These were thawed, and organisms were harvested by centrifugation at 19,000 x g for 10 min. M. fermentans PG18 was metabolically labeled with L-35S-cysteine (specific activity, 975 Ci/mmol; Dupont, NEN Research Products, Boston, Mass.) or 9,10-3H-palmitate (specific activity, 28 Ci/mmol; Dupont, NEN), using methods described in detail elsewhere (13) .
Mycoplasma protein fractionation and analysis. Detergent phase fractionation of M. fermentans with Triton X-114 (TX-114) was carried out as described in detail elsewhere, using unlabeled or metabolically labeled organisms (13, 25) . Mycoplasma proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie blue or silver (28) or electrophoretically transferred to nitrocellulose filters and immunostained as described before (13, 25, 26) . Relative molecular masses were determined with prestained protein standards (Diversified Biotech, Newton Center, Mass.). In some experiments, 2-mercaptoethanol was omitted from the SDS-PAGE sample buffer to assess the migration of proteins under nonreducing conditions. Radiolabeled proteins were detected by autoradiography or fluorography, as described previously (13) .
Preparation of antibodies to M. fermentans. Polyclonal antiserum to whole M. fermentans PG18 organisms from broth-grown cultures was generated in 10-week-old female BALB/c mice by intraperitoneal injection of 100 ,g of protein emulsified in Freund incomplete adjuvant (Difco Laboratories, Detroit, Mich.), given four times at weekly intervals. Polyclonal antiserum to membrane proteins was generated by the same regimen, but with the injection of 100 ,ug of TX-114-phase proteins from M. fennentans PG18. Specific mouse antiserum to P41 lipoprotein was obtained by excising the prominent 41-kDa component from an SDSpolyacrylamide gel loaded with methanol-precipitated M. fennentans PG18 TX-114-phase protein prepared from 4 mg of broth-grown organisms. This method has been described elsewhere (25 were screened by enzyme-linked immunosorbent assay, using growth medium serum as a target, to eliminate those hybridomas reacting with serum components. The remainder were cloned by limiting dilution in 96-well microtiter plates, using hybridoma growth media supplemented with hypoxanthine-aminopterin-thymidine and BALB/c mouse peritoneal macrophages (4 x 104 per ml). The isotypes of MAbs were determined by Western blot (using M. fermentans antigen as a target) by probing with MAb and then developing blots with heavy-and light-chain, isotype-specific goat anti-mouse antibody (Southern Biotechnology Associates, Inc., Birmingham, Ala.). Other reagents included a MAb (G29H8) generated to M. fermentans Incognitus by methods described previously (7, 8) and a MAb (F177C21A) to the internal hydrophilic protein P66 shared by several mycoplasma species, including M. fermentans, described elsewhere (6, 25) .
Trypsin treatment of intact mycoplasmas. Intact organisms were treated with trypsin by a variation of a previously described method (13) . Briefly, mycoplasmas were harvested by centrifugation from early-log-phase broth cultures and pelleted organisms were washed and resuspended in TS buffer (50 mM Tris, 145 mM NaCl; pH 7.3). Identical portions containing washed organisms from 2 After 3 min at room temperature, SDS-PAGE sample buffer was added, and the samples were heated for 5 min at 100°C and subjected to SDS-PAGE. Gels were stained with silver or were used to generate immunoblots, which were probed with antibodies to specific membrane proteins. To demonstrate the trypsin sensitivity of the P66 protein (an internal marker for cell integrity during digestion) (6), organisms were processed without trypsin inhibitor in the presence of SDS-PAGE sample buffer to lyse organisms. Abrogation of MAb binding to P66 was shown in detergent-disrupted mycoplasmas treated with trypsin (not shown).
RESULTS
Lipoproteins constitute major integral membrane proteins of M. fermnentans. Integral membrane proteins of M. fermentans PG18 were identified and characterized by detergent phase partitioning of whole organisms metabolically labeled with 3 S-cysteine, as described previously for other species (12, 13, 25) . TX-114 phase fractionation revealed a limited set of metabolically labeled proteins that selectively partitioned into the detergent phase (Fig. 1A) . These amphiphilic proteins were provisionally defined as integral membrane proteins of strain PG18 on the basis of their preferential interaction with detergent micelles during this fractionation protocol. Separation by SDS-PAGE under reducing (Fig. 1) or nonreducing (not shown) conditions gave essentially the same protein profiles, suggesting that the Cys-containing amphiphilic proteins were not linked to other proteins through interchain disulfide bonds.
Parallel detergent fractionation of organisms metabolically labeled with 3H-palmitate (Fig. 1B) revealed that (i) several proteins of strain PG18 were metabolically labeled with palmitate, (ii) palmitate-labeled proteins exclusively partitioned into the detergent phase (with one exception), and (iii) when resolved in the same gel, palmitate-labeled TX-114-phase proteins aligned precisely with their 35S-cysteinelabeled counterparts. The combined resolution of TX-114 phase fractionation and SDS-PAGE thus enabled clear identification of several amphiphilic proteins with properties consistent with procaryotic lipoproteins, notably, the presence of at least one Cys residue, the presence of stably associated fatty acids, and a predicted amphiphilic character. Because of the extended times of autoradiography required for detection of the 3H label in these experiments, it was not possible to determine whether some proteins that labeled only weakly with 35S-cysteine were also labeled with 3H-palmitate. Table 1 indicates some of the proteins identified as putative lipoproteins, along with other additional properties identified below.
Membrane lipoproteins are antigenic and can be distinguished by species-specific MAbs. Murine antibodies raised by inoculation of whole, broth-grown strain PG18 organisms M. fermentans PG18 was phase fractionated, and whole organisms (T), aqueous-phase proteins (Aq), or TX-114-phase proteins (X) were separated by SDS-PAGE and immunoblotted with murine antiserum to whole broth-grown organisms (A) or to TX-114-phase proteins (B) or with a combination of the MAbs and the specific PAb to P41, listed in Table 1 were shown by immunoblotting to bind several proteins of the organism (Fig. 2A) . Inclusion of serum during incubation of blots with primary antibody did not affect staining patterns (not shown), indicating that the proteins recognized were of mycoplasma origin and that the patterns observed were not due to antibodies directed to serum proteins from the broth medium used to grow the inoculum. Interestingly, amphiphilic detergent-phase components were most intensively stained by this antiserum ( Fig. 2A) , whereas only a small proportion of the more numerous hydrophilic constituents in the aqueous phase were stained. Murine antiserum generated by injection of the TX-114-phase components of strain PG18 also predominantly recognized amphiphilic proteins, as expected (Fig. 2B) . Some antigens recognized by these two antisera appeared only in the sample containing whole organisms and may have been incompletely solubilized during initial detergent extraction. Antiserum to TX-114-phase proteins also recognized some antigens selectively present in the total and aqueous-phase fractions, possibly because of minor contaminating aqueous-phase proteins in the TX-114 phase used to immunize, or cross-reactive epitopes with TX-114-phase components.
To further define and characterize individual membrane proteins of strain PG18, MAbs were generated from mice immunized with TX-114-phase proteins and initially screened for the ability to bind whole organisms immobilized on nitrocellulose filters. Several of these MAbs were subsequently shown to be directed to stable epitopes on integral membrane proteins, as demonstrated by immunoblots of TX-114-phase proteins separated by SDS-PAGE (Fig. 2C) . Notably, each MAb bound a distinct epitope displayed on a discrete component (Fig. 2D ). Immunoblotting and autoradiography of proteins radiolabeled with 35S-cysteine and subjected to detergent phase fractionation and SDS-PAGE showed precise alignment of individual MAb-defined antigens with radiolabeled proteins (not shown), including those identified in Table 1 as lipoproteins. Since not all lipoproteins were detected with this initial library of MAbs, specific antiserum was raised to other TX-114-phase components. Table 1 , as described in Materials and Methods. Lanes 1 through 5 represent organisms treated, respectively, with 0.016, 0.080, 0.4, 2, or 8 mg of trypsin per ml, which is apparent as an intensifying band (T) in panel A. Panel B represents the relevant portions of the corresponding immunoblot stained with specific antibodies to the proteins indicated. One blot (P66) was stained with a previously described MAb to an internal protein, P66 (6, 25) . In separate experiments, P66 was shown to be sensitive to similar levels of trypsin in detergentdisrupted organisms (data not shown).
The major palmitate-labeled protein band of 41 kDa (Fig. 1 ) was excised after SDS-PAGE separation of TX-114-phase proteins and used to generate a murine polyclonal antibody (PAb), using procedures described in Materials and Methods. This reagent specifically recognized TX-114-phase proteins migrating at 41 kDa ( Fig. 2C and D) but not any other aqueous-or TX-114-phase components.
To assess whether antibodies were directed to epitopes restricted to the species M. fermentans, organisms from broth cultures of 13 other human mycoplasma species and five animal species were assayed in parallel with M. fermentans PG18 by Western immunoblot, using a combination of specific antibodies to stain equivalent amounts of each species. None of the other species (listed in Materials and Methods) revealed any component immunostaining with MAbs to M. fermentans (data not shown), indicating that these reagents were operationally species specific.
Membrane lipoproteins are exposed on the surface of M.
fermentans. The localization of membrane proteins on the external surface of M. fermentans was examined, using the antibody reagents to individual proteins noted above to monitor selective susceptibility of antigens to graded trypsin digestion of intact organisms prepared from fresh broth cultures. While treatment of cells with increasing concentrations of trypsin failed to alter the general protein-staining profile of organisms (Fig. 3A) , immunoblots of these identical preparations with antibodies to specific membrane proteins showed graded abrogation of staining or generation of smaller degradation products (Fig. 3B) . In contrast to antibodies to membrane proteins, a previously described MAb to the internal hydrophilic protein P66, shared by several mycoplasma species including M. ferinentans (6, 25) , was used to establish the resistance of P66 during trypsin digestion of intact cells (Fig. 3B) . P66 was susceptible, however, to trypsin degradation in disrupted cells (6; data not shown). The selective susceptibility to enzymatic proteolysis of intact cells indicated that the membrane proteins listed in Table 1 were surface-exposed antigenic components.
Strain differences in M. fermentans surface lipoprotein structure and expression profiles. Several mycoplasmas show intraspecies variation in the patterns of surface proteins displayed, as well as structural alternatives for specific surface proteins expressed (reviewed in reference 27). Recent reports have identified differences in profiles of antigenic components among strains of M. fermentans, although the biochemical nature and cellular location of these components have not been extensively defined (15, 18) . Using the specific MAb and PAb reagents described in this report, we were able to establish differences between stock cultures of M. fermentans PG18 and Incognitus in the distribution and structural features of specific surface membrane lipoproteins present.
SDS-PAGE analysis of whole, broth-grown organisms revealed differences between strains PG18 and Incognitus in patterns of components stained with Coomassie blue (not shown) and with silver (Fig. 4A) , as reported by others (15, 18) . Immunoblot analysis of gels, similarly loaded with equivalent amounts of each strain, showed more striking differences (Fig. 4B through J (Fig. 4C) . This difference was confirmed in multiple preparations of strain Incognitus containing protease inhibitor, in which other membrane proteins defined by MAbs to PG18 proteins were present and in fact appeared to be more abundant (see below). These observations argue against general proteolytic degradation as an explanation for the difference between strains in the size of this membrane protein.
Second, other MAbs defined apparent differences in the relative amounts of specific membrane proteins associated with organisms derived from broth cultures of the two strains ( Fig. 4B through J) . For example, MAb to P95 in strain PG18 revealed no detectable antigen in strain Incognitus. In another pattern, MAb to PG18 antigen P61, P38, or P29 showed much weaker staining of the respective proteins in strain Incognitus. Finally, MAb to P78 and PAb to P41 of PG18 showed stronger relative staining of the respective proteins in strain Incognitus. Although not rigorously quantitative, immunoblots with specific antibodies on identical pairs of whole, broth-grown organisms indicate that the stock cultures of PG18 and Incognitus differ in the relative amounts or forms of individual surface antigens. A difference between these two strains has been found previously in dot blot assays with MAbs raised against strain Incognitus that were specific for that strain (7, 8) . One such MAb is shown in Fig. 4I 
DISCUSSION
The lipid-associated membrane proteins of M. fernentans resemble lipoproteins of other mycoplasma species that are displayed as abundant diverse components on the membrane surface and are often highly antigenic or immunogenic (1, 2, 6, 22, 23, 25, 27) . Lipid modification seems to be a critical and widespread structural modification for anchoring various proteins to the exterior surface of the single mycoplasma membrane (24) . The variety and antigenic structure of surface lipoproteins on M. fermentans are noteworthy. Several discrete, lipid-modified translational products carrying distinctive epitopes were demonstrated. While the precise nature of these antigenic structures could not be determined, they were clearly associated with proteins identified by metabolic labeling and trypsin sensitivity. Moreover, two MAb-defined epitopes have recently been detected on recombinant products expressed in Escherichia coli from M. fennentans genomic fragments (19, 20) , indicating that at least some epitopes are determined by encoded protein sequence, as similarly determined for other mycoplasma lipoproteins (6, 30) . If these components are typical procaryotic (29) and mycoplasmal (24) lipoproteins, their translocation across the single membrane would result in export of most of the protein-coding sequence to the external surface of the organism, where they would provide a potentially important antigenic interface with the host and could serve several other functions associated with adaptation and survival (24) .
The MAb reagents generated here will be useful in further characterizing surface variation of M. fermentans. In other studies, general protein patterns have been shown to differ among strains of this species, including some products identified by hyperimmune serum antibodies, using SDS-PAGE of unfractionated organisms (15, 18) . Our results show that antigenic differences within the species are directly associated with the family of surface membrane lipoproteins defined here. We identified one difference between strains in the respective sizes of products bearing a defined epitope. We could also detect apparent differences between strains in the relative amounts of some epitopebearing membrane proteins, with some products quite selectively associated with a particular strain. The bases for these quantitative differences are not yet established. Notably, M. fermentans populations were analyzed as standard passaged cultures that had been propagated since initial isolation and cloning. Expression profiles measured under these conditions therefore represent average properties and could reflect differences in all or only some members of the population (12, 13, 27) . Indeed, recent analysis (19, 20) suggests that marked population diversification involving expression of surface lipoproteins occurs in M. fermentans. Irrespective of the basis underlying observed strain differences, it is now clear that careful definition of surface phenotypic markers must be considered in defining strains or populations of M. fermentans. For instance, genotypic differences involving restriction fragment length polymorphism associated with an insertion sequence-like element of M. fermentans differentiate isolates of the organism (7). However, others have reported lack of restriction fragment length polymorphism as a measure of similarity (16) but did not address evidence from Western immunoblot patterns, suggestive of strainvariant components similar to those we report here. Critical assessment of individual components will be needed to establish patterns of variation in surface membrane proteins.
Our results underscore the inherent limitations in attempts to assess serologic responses to M. fennentans in humans without definition of specific target antigens. The current difficulty in obtaining meaningful patterns of serum antibody reactivity to M. fermentans has been discussed recently (22) . In one limited study (5) monitoring human serologic responses to whole organism preparations of M. fermentans, association of M. fernentans infection with human immunodeficiency virus infection was not supported. However, several factors may influence serologic analyses of this sort. First, the possibility must be considered that distinctive immune responses may occur in individuals because of expression of particular antigenic alternatives of M. fermentans. The surface lipoproteins described here may therefore be interesting as potential immunogens in the host that could, through variable expression patterns, determine the nature, intensity, or composite specificities of the host response to the organism. These individual products may be particularly useful in developing highly specific assays for monitoring such selective host responses. Second, the definition of phenotypes distinguishing populations of M. fermentans is critical. Shortcomings in attempts to associate phenotypes measured in vitro with properties of a population in vivo have been discussed elsewhere (13, 27) . Since understanding the phenotypic characteristics of organisms as they reside in the host is ultimately required, reagents such as the MAbs developed here may be powerful tools to examine the agent in its natural state as an infectious agent or pathogen. Studies by one of us (S.-C.L.) to determine the distribution of the surface components on organisms associated with disease lesions in humans are under way.
